Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.3795
-0.0107 (-2.74%)
At close: Oct 14, 2026, 4:00 PM EDT
0.3771
-0.0024 (-0.63%)
After-hours: Oct 14, 2026, 7:41 PM EDT
Evogene Market Cap
Evogene has a market cap or net worth of $6.03 million as of October 14, 2026. Its market cap has decreased by 46.68% in one year.
Market Cap
6.03M
Enterprise Value
7.80M
1-Year Change
-46.68%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from $28.02M to $6.03M, a decrease of -78.49%. That is a compound annual growth rate of -7.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 6.44M | -21.69% |
| Dec 31, 2025 | 8.22M | -36.78% |
| Dec 31, 2024 | 13.00M | -69.10% |
| Dec 31, 2023 | 42.08M | 60.85% |
| Dec 29, 2022 | 26.16M | -63.27% |
| Dec 30, 2021 | 71.23M | -58.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Skye Bioscience | 6.95M |
| FibroBiologics | 6.61M |
| XTL Biopharmaceuticals | 6.49M |
| Alzamend Neuro | 6.42M |
| Niki BioSolutions | 6.30M |
| Enveric Biosciences | 6.13M |
| Traws Pharma | 6.09M |
| Acurx Pharmaceuticals | 6.06M |